GO:0098554 cytoplasmic side of endoplasmic reticulum membrane: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0098554 defines the cytoplasmic leaflet of the endoplasmic reticulum (ER) membrane, including proteins embedded in, attached to, or peripherally associated with this surface [2, 4].
• This compartment is the docking platform for co-translational protein translocation, intramembrane chaperone activity, and ER-associated degradation (ERAD) [2, 7].
• Key proteins at this face include multipass membrane protein chaperones, phosphatidylserine synthase 1 (PTDSS1), and Rft1, which are implicated in congenital disorders of glycosylation and membrane lipid homeostasis [3, 4].
• The cytoplasmic side of the ER membrane is a hub for ubiquitin-dependent quality control and ER stress signaling that contributes to heart disease and primary open-angle glaucoma [1, 5, 7].
• Membrane property sensors and the unfolded protein response (UPR) integrate lipid bilayer status with transcriptional outputs at this interface.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of genes functioning at the cytoplasmic ER surface [2, 3, 7].
Description
The cytoplasmic side of the endoplasmic reticulum membrane (GO:0098554) is the leaflet of the ER membrane that faces the cytosol, encompassing any protein embedded in, attached to, or peripherally associated with it [2, 4]. This compartment is functionally distinct from the ER lumen and is the first point of contact for cytosolic factors that regulate protein biogenesis, membrane lipid synthesis, and quality control [2, 7]. Because the ER is the entry site for most secretory and membrane proteins, the cytoplasmic face coordinates ribosome docking, chaperone recruitment, and ubiquitin-dependent degradation [2, 7]. Researchers study this term to understand how membrane protein topogenesis, lipid homeostasis, and stress signaling are spatially organized [3, 4, 8]. Defects in proteins localized to this surface are linked to congenital glycosylation disorders, glaucoma, and cardiac ER stress, making it a high-value target for functional genomics [1, 3, 5].
cytoplasmic side of endoplasmic reticulum membrane At A Glance
| GO ID | GO:0098554 |
|---|---|
| GO term | cytoplasmic side of endoplasmic reticulum membrane |
| Ontology | cellular_component |
| Synonym | None listed in QuickGO |
| Major function | Platform for co-translational translocation, intramembrane chaperone activity, ERAD, and lipid synthesis [2, 4, 7] |
| Associated proteins | Multipass membrane protein chaperones, PTDSS1, Rft1, ubiquitin ligases, and ER stress sensors [2, 3, 4, 7, 8] |
| Disease relevance | Congenital disorder of glycosylation RFT1-CDG, primary open-angle glaucoma, cardiac ER stress [1, 3, 5] |
| Research methods | CRISPR KO/point mutation/knock-in/overexpression, proteomics, imaging, and ERAD assays [2, 3, 7] |
What Is GO:0098554?
GO:0098554 describes the cytoplasmic leaflet of the endoplasmic reticulum membrane, including integral membrane proteins whose domains face the cytosol, peripheral membrane proteins, and proteins transiently or stably attached to this surface [2, 4]. It is a cellular component term that excludes the ER lumen and the luminal leaflet, and it is used to annotate gene products that function at the cytosolic interface of the ER [2, 7].
Why Is cytoplasmic side of endoplasmic reticulum membrane Important in Cell Biology?
The cytoplasmic side of the ER membrane is essential because it hosts the machinery that decides the fate of newly synthesized membrane and secretory proteins, from folding and glycosylation to ubiquitin-mediated degradation [2, 7]. It also integrates lipid metabolic enzymes such as PTDSS1 and Rft1, whose dysfunction causes human disease [3, 4]. Understanding this compartment provides mechanistic insight into ER stress, UPR signaling, and organelle communication relevant to glaucoma, heart disease, and glycosylation disorders [1, 5, 8].
• Serves as the docking site for ribosomes and intramembrane chaperones during multipass membrane protein biogenesis.
• Coordinates ER-associated degradation (ERAD) through ubiquitin modification at the cytosolic face.
• Hosts phosphatidylserine synthase 1 (PTDSS1), a key enzyme for phospholipid synthesis.
• Contains Rft1, a flippase-like ER membrane protein required for N-glycosylation, linked to RFT1-CDG.
• Participates in ER stress responses implicated in primary open-angle glaucoma.
• Contributes to cardiac ER stress biology and heart disease progression.
• Integrates membrane property sensing with the unfolded protein response.
• Provides a target for CRISPR functional screens of membrane protein biogenesis [2, 7].
• Enables study of mitochondria-associated ER membranes (MAMs) and organelle crosstalk.
• Supports development of therapeutic strategies for glycosylation and neurodegenerative disorders [3, 5].
What Happens During cytoplasmic side of endoplasmic reticulum membrane?
Co-translational translocation and ribosome docking
In simple terms: New proteins are threaded into the ER while they are still being made, and the cytosolic side is where the ribosome and chaperones first engage.
The cytoplasmic face of the ER membrane is the initial site for co-translational translocation of secretory and membrane proteins. Multipass membrane proteins require intramembrane chaperones that operate at this leaflet to facilitate their folding and assembly. This step is tightly coupled to ribosome docking and early quality control decisions [2, 7].
Intramembrane chaperone activity
In simple terms: Specialized chaperones inside the membrane help complex proteins fold correctly from the cytosolic side.
Intramembrane chaperones such as those studied by Smalinskaitė et al. (2022) act on multipass membrane proteins at the cytoplasmic side of the ER membrane, preventing misfolding and promoting proper topology. These chaperones are essential for the biogenesis of polytopic membrane proteins and are conserved across eukaryotes.
ER-associated degradation (ERAD)
In simple terms: Misfolded proteins are tagged with ubiquitin on the cytosolic side and sent for destruction.
The cytoplasmic side of the ER membrane is the platform for ERAD, where ubiquitin ligases and associated factors recognize misfolded or unassembled proteins and modify them with ubiquitin for proteasomal degradation. This process is critical for protein quality control and is regulated by the ubiquitin-proteasome system.
Lipid synthesis and membrane homeostasis
In simple terms: Enzymes on the cytosolic side make lipids that shape the ER membrane.
Phosphatidylserine synthase 1 (PTDSS1) is a membrane protein whose topology places its active site at the cytoplasmic side of the ER membrane, where it catalyzes phosphatidylserine synthesis. Rft1, another ER membrane protein, is involved in flipping lipid-linked oligosaccharides and is associated with congenital disorder of glycosylation RFT1-CDG. These enzymes maintain membrane lipid composition and support glycosylation reactions [3, 4].
ER stress sensing and UPR signaling
In simple terms: The cytosolic face detects membrane stress and triggers adaptive responses.
Membrane property sensors and the unfolded protein response (UPR) integrate signals from the ER membrane, including its cytoplasmic side, to regulate transcriptional outputs. In the heart, ER stress responses at this interface contribute to cardiac pathology. In primary open-angle glaucoma, genetic and ER-mediated mechanisms involving this compartment have been described.
Key Genes Involved in GO:0098554 cytoplasmic side of endoplasmic reticulum membrane
The following genes and proteins localize to or function at the cytoplasmic side of the endoplasmic reticulum membrane (GO:0098554) and are supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PTDSS1 | Phosphatidylserine synthase 1; catalyzes phosphatidylserine synthesis at the cytoplasmic leaflet | Lipid metabolism and membrane topology studies |
| RFT1 | ER membrane protein involved in N-glycosylation; mutations cause RFT1-CDG | Congenital disorders of glycosylation research |
| DERL1 | ERAD component; recognizes misfolded proteins at the cytosolic face | Protein quality control and ubiquitin biology |
| DERL2 | ERAD component; facilitates retrotranslocation | ERAD mechanism studies |
| SEL1L | ERAD adaptor; recruits substrates for ubiquitination | ER stress and degradation research |
| HRD1 | Ubiquitin ligase in ERAD; acts at the cytoplasmic side | Ubiquitin modification and ERAD |
| VCP/p97 | AAA-ATPase; extracts ubiquitinated proteins from the ER membrane | ERAD and proteostasis |
| ATF6 | ER stress sensor; translocates to Golgi upon activation | UPR signaling |
| IRE1 | ER stress sensor; splices XBP1 mRNA | UPR and membrane property sensing |
| PERK | ER stress kinase; phosphorylates eIF2α | Integrated stress response |
| CANX | Calnexin; chaperone at the ER membrane | Glycoprotein folding |
| CALR | Calreticulin; chaperone in the ER lumen but interacts with membrane components | Protein folding and quality control |
| SEC61A1 | Core translocon component; forms the protein-conducting channel | Co-translational translocation |
| GET1 | Guides tail-anchored proteins to the ER membrane | Membrane protein targeting |
| GET2 | Part of the GET complex for tail-anchored protein insertion | Membrane protein biogenesis |
| GET3 | Cytosolic ATPase that delivers tail-anchored proteins | Post-translational targeting |
| BAG6 | Chaperone involved in tail-anchored protein targeting | Membrane protein quality control |
How Is cytoplasmic side of endoplasmic reticulum membrane Regulated?
The cytoplasmic side of the ER membrane is regulated by membrane property sensors and the unfolded protein response (UPR), which detect lipid bilayer stress and protein folding status. Ubiquitin modification dynamically controls ERAD activity at this surface, with ubiquitin ligases and deubiquitinases balancing substrate selection. ER stress signaling pathways, including PERK, IRE1, and ATF6, modulate gene expression to adapt to changing conditions. In cardiac tissue, ER stress responses are regulated by multiple signaling cascades that influence disease progression. Additionally, mitochondria-associated ER membranes (MAMs) provide a regulatory interface that can influence ER membrane dynamics.
cytoplasmic side of endoplasmic reticulum membrane and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RFT1 | RFT1-CDG (congenital disorder of glycosylation) | Knockout or point-mutation in cell lines; glycosylation assays |
| PTDSS1 | Membrane lipid homeostasis; potential neurological disorders | Overexpression and knockout for lipid profiling |
| DERL1 | ERAD dysfunction; cancer and neurodegeneration | Knockout and tagged knock-in for degradation assays |
| ATF6 | ER stress-related diseases; glaucoma and heart disease [1, 5, 8] | Knockout and overexpression for UPR reporter assays |
| IRE1 | UPR-related pathologies; metabolic and inflammatory diseases | Point mutation and knockout for XBP1 splicing assays |
Primary open-angle glaucoma
Genetic and endoplasmic reticulum-mediated molecular mechanisms contribute to primary open-angle glaucoma, with ER stress and protein quality control pathways at the cytoplasmic side of the ER membrane implicated in disease pathogenesis. Mutations affecting ER function can lead to trabecular meshwork dysfunction and elevated intraocular pressure.
Congenital disorder of glycosylation RFT1-CDG
Mutations in RFT1, an ER membrane protein associated with the cytoplasmic side, cause RFT1-CDG, a congenital disorder of glycosylation characterized by defective N-linked glycosylation. Molecular characterization of Rft1 has revealed its role in flipping lipid-linked oligosaccharides across the ER membrane.
Cardiac ER stress and heart disease
ER stress responses at the cytoplasmic side of the ER membrane contribute to cardiac pathology, including ischemia-reperfusion injury and heart failure. The UPR and ERAD are activated in cardiomyocytes under stress, influencing cell survival and function.
Chemotherapy-induced diarrhea and MAMs
Mitochondria-associated endoplasmic reticulum membranes (MAMs) regulate ER-mitochondria communication, and components at the cytoplasmic side of the ER membrane are involved in chemotherapy-induced diarrhea pathogenesis. Targeting MAMs may provide therapeutic strategies.
From cytoplasmic side of endoplasmic reticulum membrane-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of RFT1 affect N-glycosylation at the cytoplasmic side? | CRISPR knockout of RFT1 in HEK293 or HeLa cells |
| How does PTDSS1 topology influence phosphatidylserine synthesis? | Point mutation of catalytic residues and knock-in of tagged PTDSS1 |
| What is the role of DERL1 in ERAD substrate recognition? | Knockout and overexpression of DERL1 with ubiquitin assays |
| How do UPR sensors respond to membrane stress? | Knock-in of fluorescent reporters for ATF6, IRE1, and PERK |
| Does Rft1 mutation cause congenital glycosylation defects? | Patient-derived iPSCs with point mutation and isogenic controls |
| Can overexpression of chaperones rescue multipass protein folding? | Overexpression of intramembrane chaperones in knockout backgrounds |
How to Study the cytoplasmic side of endoplasmic reticulum membrane Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Proteomics (LC-MS/MS) | Protein composition and interactions at the cytoplasmic side [2, 7] | Identifying ER membrane protein complexes |
| Selective permeabilization | Membrane topology and leaflet localization | Determining cytoplasmic vs luminal domains |
| Cycloheximide chase | Degradation kinetics of ERAD substrates | ERAD functional assays |
| Ubiquitin pull-down | Ubiquitination levels of ER proteins | Quality control studies |
| CRISPR knockout screens | Genes required for ER membrane functions [2, 7] | Functional genomics of ER biogenesis |
| Fluorescence microscopy | Subcellular localization and dynamics [4, 6] | Imaging ER membrane domains |
| Glycosylation assays | N-linked glycosylation efficiency | RFT1-CDG modeling |
| UPR reporter assays | Activation of ATF6, IRE1, PERK | ER stress signaling studies |
Proteomics and interactomics
Mass spectrometry-based proteomics can identify proteins enriched at the cytoplasmic side of the ER membrane, including peripheral and integral membrane proteins [2, 7]. Affinity purification of tagged ER membrane proteins followed by LC-MS/MS reveals interaction partners and dynamic changes during ER stress.
Imaging and topology assays
Fluorescence microscopy with tagged proteins and selective permeabilization can determine membrane topology and localization to the cytoplasmic leaflet. Super-resolution imaging and electron microscopy of MAMs provide spatial context for ER membrane domains.
ERAD and ubiquitination assays
Cycloheximide chase assays combined with immunoprecipitation measure degradation kinetics of ERAD substrates. Ubiquitination status can be assessed by pull-down with ubiquitin-binding domains and western blotting.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout screens can identify genes required for ER membrane protein biogenesis and quality control [2, 7]. Pooled screens with reporters of ER stress or glycosylation enable discovery of regulators at the cytoplasmic side [3, 8].
How CRISPR Can Be Used to Study GO:0098554 cytoplasmic side of endoplasmic reticulum membrane
Knockout
CRISPR knockout of genes encoding proteins at the cytoplasmic side of the ER membrane, such as RFT1 or DERL1, enables loss-of-function studies to assess glycosylation defects or ERAD impairment [3, 7]. Knockout cell lines are valuable for identifying compensatory pathways and for drug sensitivity screens.
Point Mutation
Introducing disease-associated point mutations, such as those in RFT1 or PTDSS1, allows precise modeling of congenital disorders and functional dissection of catalytic residues [3, 4]. Point-mutant knock-in lines can reveal dominant-negative or hypomorphic effects.
Knock-in
Knock-in of epitope tags or fluorescent reporters at endogenous loci facilitates live-cell imaging and proteomic analysis of proteins at the cytoplasmic side [4, 7]. Tagged knock-in models preserve native regulation and are ideal for interaction studies.
Overexpression
Overexpression of ER membrane proteins or chaperones can rescue folding defects or exacerbate ER stress, providing gain-of-function insights [2, 8]. Overexpression models are useful for testing therapeutic candidates targeting the cytoplasmic ER surface.
How EDITGENE Supports cytoplasmic side of endoplasmic reticulum membrane Research
Researchers studying cytoplasmic side of endoplasmic reticulum membrane-related genes often need to determine whether a candidate gene is causally involved in ER protein biogenesis, lipid homeostasis, or stress signaling. EDITGENE provides comprehensive CRISPR services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for cytoplasmic side of endoplasmic reticulum membrane research.
Frequently Asked Questions About cytoplasmic side of endoplasmic reticulum membrane
What is GO:0098554?
GO:0098554 is the Gene Ontology term for the cytoplasmic side of the endoplasmic reticulum membrane, the leaflet facing the cytosol including associated proteins [2, 4].
What genes are involved in the cytoplasmic side of the endoplasmic reticulum membrane?
Key genes include PTDSS1, RFT1, DERL1, DERL2, SEL1L, HRD1, VCP, ATF6, IRE1, PERK, and SEC61A1, among others [2, 3, 4, 7, 8].
What is the function of the cytoplasmic side of the ER membrane?
It serves as a platform for co-translational translocation, intramembrane chaperone activity, ERAD, lipid synthesis, and ER stress sensing [2, 4, 7, 8].
How is the cytoplasmic side of the ER membrane studied?
Common methods include proteomics, imaging, ERAD assays, glycosylation assays, and CRISPR screens [2, 3, 7].
What diseases are linked to the cytoplasmic side of the ER membrane?
Diseases include RFT1-CDG, primary open-angle glaucoma, cardiac ER stress, and chemotherapy-induced diarrhea involving MAMs [1, 3, 5, 6].
What is the role of RFT1 at the ER membrane?
RFT1 is an ER membrane protein involved in N-glycosylation; mutations cause RFT1-CDG.
How does PTDSS1 function at the cytoplasmic side?
PTDSS1 catalyzes phosphatidylserine synthesis at the cytoplasmic leaflet of the ER membrane.
What is ERAD and how does it relate to GO:0098554?
ERAD is ER-associated degradation, a quality control process that occurs at the cytoplasmic side of the ER membrane and involves ubiquitination.
Can CRISPR be used to study GO:0098554?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to study genes at this compartment [2, 3, 7].
What is the clinical relevance of the cytoplasmic side of the ER membrane?
It is relevant to congenital glycosylation disorders, glaucoma, heart disease, and cancer, making it a target for therapeutic development [1, 3, 5].
Conclusion
The cytoplasmic side of the endoplasmic reticulum membrane (GO:0098554) is a functionally critical compartment that coordinates protein biogenesis, quality control, lipid synthesis, and stress signaling [2, 4, 7, 8]. Its roles in congenital disorders, glaucoma, and cardiac disease underscore its biomedical importance [1, 3, 5]. Advances in CRISPR-based models and proteomic methods continue to illuminate the molecular mechanisms at this interface, offering new opportunities for therapeutic intervention [2, 7].
References
- 1. Rozpędek-Kamińska W et al.. 2020. The Genetic and Endoplasmic Reticulum-Mediated Molecular Mechanisms of Primary Open-Angle Glaucoma.. Int J Mol Sci 21(11) PMID: 32545285
- 2. Smalinskaitė L et al.. 2022. Mechanism of an intramembrane chaperone for multipass membrane proteins.. Nature 611(7934):161-166 PMID: 36261528
- 3. Hirata E et al.. 2024. Molecular characterization of Rft1, an ER membrane protein associated with congenital disorder of glycosylation RFT1-CDG.. J Biol Chem 300(8):107584 PMID: 39025454
- 4. Miyata N et al.. 2021. Topology of phosphatidylserine synthase 1 in the endoplasmic reticulum membrane.. Protein Sci 30(11):2346-2353 PMID: 34516042
- 5. Groenendyk J et al.. 2010. Biology of endoplasmic reticulum stress in the heart.. Circ Res 107(10):1185-97 PMID: 21071716
- 6. Cao Z et al.. 2026. Mechanism of Shenzhu components in alleviating chemotherapy-induced diarrhea via mitochondria-associated endoplasmic reticulum membranes (MAMs) regulation.. J Ethnopharmacol 358:120958 PMID: 41317807
- 7. Preston GM et al.. 2017. The evolving role of ubiquitin modification in endoplasmic reticulum-associated degradation.. Biochem J 474(4):445-469 PMID: 28159894
- 8. Covino R et al.. 2018. Integrated Functions of Membrane Property Sensors and a Hidden Side of the Unfolded Protein Response.. Mol Cell 71(3):458-467 PMID: 30075144
